Clinical Trial Update: Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the pharmacokinetics, safety, and tolerability of ertugliflozin in healthy Japanese and Western participants. The study did not inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ertugliflozin (ertugliflozin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED